Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement

NCT01804283 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT01804283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Ischemic Postconditioning on Expression of Apoptosis-related MicroRNAs and Genes in Human Double Valve Replacement
Lead sponsor
Central South University
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2013
Completion date
Not reported
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, ischemic postconditioning